Form Bio Co. Ltd. Strategic Asset Allocation Index
Form Bio Co. Ltd. strategic asset allocation index. Form Bio Co. Ltd. (377220) has a Strategic Asset Allocation Index of 74.7% as of September 2024. Strategic assets (PP&E of ₩46.28 Billion plus long-term investments of ₩-) total ₩46.28 Billion, measured against net assets of ₩61.95 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Form Bio Co. Ltd. (377220) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Form Bio Co. Ltd. (2020–2022)
Strategic asset allocation index of Form Bio Co. Ltd. from 2020 to 2022. This chart shows how Form Bio Co. Ltd.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 74.7%, representing strategic assets of ₩46.28 Billion against net assets of ₩61.95 Billion KRW. Check 377220 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Form Bio Co. Ltd. Strategic Asset Allocation Index by Year (2020–2022)
Form Bio Co. Ltd. strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Form Bio Co. Ltd. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Form Bio Co. Ltd. (377220) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 37.9% | ₩33.31 Billion | ₩33.31 Billion | ₩- | ₩87.96 Billion | ▲ +13.8 pp |
| 2021 | 24.1% | ₩20.33 Billion | ₩20.33 Billion | ₩- | ₩84.43 Billion | ▼ -28.9 pp |
| 2020 | 52.9% | ₩12.51 Billion | ₩12.51 Billion | ₩- | ₩23.64 Billion | — |